GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (OTCPK:VEXTF) » Definitions » ROE % Adjusted to Book Value

VEXTF (Vext Science) ROE % Adjusted to Book Value : -23.71% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science ROE % Adjusted to Book Value?

Vext Science's ROE % for the quarter that ended in Sep. 2024 was -11.62%. Vext Science's PB Ratio for the quarter that ended in Sep. 2024 was 0.49. Vext Science's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -23.71%.


Vext Science ROE % Adjusted to Book Value Historical Data

The historical data trend for Vext Science's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science ROE % Adjusted to Book Value Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 6.85 2.80 8.83 44.95 10.76

Vext Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.94 55.37 -46.76 -42.53 -23.71

Competitive Comparison of Vext Science's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vext Science's ROE % Adjusted to Book Value falls into.



Vext Science ROE % Adjusted to Book Value Calculation

Vext Science's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.27% / 0.49
=10.76%

Vext Science's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-11.62% / 0.49
=-23.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vext Science's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.

Vext Science Headlines

From GuruFocus

Q3 2022 Vext Science Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Vapen MJ Affirms No Vitamin E Acetate in Vapen Products

By PRNewswire PRNewswire 09-12-2019

Vapen MJ Announces Name Change to Vext Science, Inc.

By PRNewswire PRNewswire 11-07-2019

Q2 2024 Vext Science Inc Earnings Call Transcript

By GuruFocus Research 08-21-2024

Vapen MJ to Ring Opening Bell at Canadian Securities Exchange

By PRNewswire PRNewswire 10-09-2019

Q1 2024 Vext Science Inc Earnings Call Transcript

By GuruFocus Research 05-30-2024

Vapen MJ Appoints Scott A. Hill, Esq. to Advisory Board

By PRNewswire PRNewswire 09-11-2019

Q4 2022 Vext Science Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024